Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neural Networks Application for Accurate Retina Vessel Segmentation from OCT Fundus Reconstruction. | Sensors (Basel) | 2023 | 36850467 | PubTator, text mining | PubMed |
| OCT guided vs. COmplete pci in patieNts with sT segment elevation myocArdial infarCtion and mulTivessel disease: OCT-CONTACT RCT. | Minerva Cardiol Angiol | 2023 | 36847434 | PubTator, text mining | PubMed |
| Macular Telangiectasia Type 2: A Classification System Using MultiModal Imaging MacTel Project Report Number 10. | Ophthalmol Sci | 2023 | 36846105 | PubTator, text mining | PubMed |
| Electronic health records in nursing from 2000 to 2020: A bibliometric analysis. | Front Public Health | 2023 | 36844821 | PubTator, text mining | PubMed |
| Novel Anticancer Strategies II. | Pharmaceutics | 2023 | 36839927 | PubTator, text mining | PubMed |
| OAT3 Participates in Drug-Drug Interaction between Bentysrepinine and Entecavir through Interactions with M8-A Metabolite of Bentysrepinine-In Rats and Humans In Vitro. | Molecules | 2023 | 36838982 | PubTator, text mining | PubMed |
| Dynamics of Epiretinal Membrane Peeling under Perfluorocarbon Liquid Evaluated by Intraoperative OCT. | Life (Basel) | 2023 | 36836611 | PubTator, text mining | PubMed |
| Intravitreal Dexamethasone Implant at the Time of Silicon Oil Removal to Treat Persistent Macular Edema after Rhegmatogenous Retinal Detachment Repair. | J Clin Med | 2023 | 36836233 | PubTator, text mining | PubMed |
| An Optimized Workflow to Generate and Characterize iPSC-Derived Motor Neuron (MN) Spheroids. | Cells | 2023 | 36831212 | PubTator, text mining | PubMed |
| Administration of Epidermal Growth Factor (EGF) and Basic Fibroblast Growth Factor (bFGF) to Induce Neural Differentiation of Dental Pulp Stem Cells (DPSC) Isolates. | Biomedicines | 2023 | 36830791 | PubTator, text mining | PubMed |
| Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review. | Biomolecules | 2023 | 36830619 | PubTator, text mining | PubMed |
| Bioactive PEEK: Surface Enrichment of Vitronectin-Derived Adhesive Peptides. | Biomolecules | 2023 | 36830615 | PubTator, text mining | PubMed |
| Agreement between a new optical low coherence reflectometry biometer and an anterior segment optical coherence tomographer. | Eye Vis (Lond) | 2023 | 36829259 | PubTator, text mining | PubMed |
| Diabetic Macular Oedema Guidelines: An Australian Perspective. | J Ophthalmol | 2023 | 36824442 | PubTator, text mining | PubMed |
| Assessing retinal hemorrhages with non-invasive post-mortem fundus photographs in sudden unexpected death in infancy. | Int J Legal Med | 2023 | 36823412 | PubTator, text mining | PubMed |
| Bacillary Layer Detachment in Diabetic Retinopathy: A Case Report. | Case Rep Ophthalmol | 2023 | 36820306 | PubTator, text mining | PubMed |
| The transcriptional program during germinal center reaction - a close view at GC B cells, Tfh cells and Tfr cells. | Front Immunol | 2023 | 36817488 | PubTator, text mining | PubMed |
| Bile duct ligation differently regulates protein expressions of organic cation transporters in intestine, liver and kidney of rats through activation of farnesoid X receptor by cholate and bilirubin. | Acta Pharm Sin B | 2023 | 36815051 | PubTator, text mining | PubMed |
| Correlation Between Imaging Morphological Findings and Laboratory Biomarkers in Patients with Retinal Vein Occlusion. | Ophthalmol Ther | 2023 | 36806996 | PubTator, text mining | PubMed |
| Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist. | J Nanobiotechnology | 2023 | 36803994 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=33